Lesley Van Wyk: JAMA – A Newly Identified Blood Group System
Lesley Van Wyk, Laboratory Manager at National Health Laboratory Service, shared a post on LinkedIn about a recent article by Tosti J. Mankelow et al, published in Vox Sanguinis, adding:
“JAMA (ISBT 049): A NEW BLOOD GROUP SYSTEM!
Immunohematology continues to evolve!
A study published in Vox Sanguinis (2026) describes the newly identified JAMA blood group system and its high-prevalence antigen, JIMI (JAMA1), carried on the JAM-A protein and encoded by the F11R gene.
An especially interesting finding is that the identified antibody recognizes JAM-A on both red blood cells and platelets, opening new avenues for research in transfusion medicine.
Although its clinical significance remains to be fully established, this discovery highlights the importance of integrating conventional serology with advanced molecular techniques.”
Title: Identification of a novel high-prevalence red blood cell antigen on junctional adhesion molecule-A defines a new blood group system
Authors: Tosti J. Mankelow, Louise A. Tilley, Vanja Karamatic Crew, Benjamin Jones, Marina Izak, Liora Muncher, Vered Yahalom, Nicole M. Thornton

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines